Related Experiment Video
Updated: Oct 1, 2026

Antagonistic Effect of Jiawei Shengjiang San on a Rat Model of Diabetic Nephropathy: Related to EGFR/MAPK3/1 Signaling Pathway
Published on: May 10, 2024
Yishen Jiangzhuo Granules affect tubulointerstitial fibrosis via a mitochondrion-mediated apoptotic pathway
Yan-fang Xu1, Shi-wei Ruan2,3, Jiu-mao Lin2
1Department of Nephrology, The First Affiliated Hospital, Fujian Medical University, Fuzhou, 350005, China. xuyanfang99@hotmail.com.
Objective:
To investigate the effect of Yishen Jiangzhuo Granules, YSJZG) on mitochondrial injury and regeneration and renal tubular epithelial cell apoptosis in chronic renal failure (CRF) rats and explore its mechanism from molecular pathology, gene, protein levels, and relative pathway.
Methods:
The CRF rat model was established using 5/6 nephrectomy. Sixty rats were randomly divided into six groups: sham-operation group, model (CRF) group, Niaoduqing Granules-treated group [5 g/(kg.day)], low-, moderate-, and high-dose [L-YSJZG, M-YSJZG, H-YSJZG at 3, 6, and 9 g/(kg day)] YSJZG-treated group (n=10 each). The levels of serum creatinine (Scr), blood urea nitrogen (BUN), and 24-h urine protein were assessed after 10 weeks of treatment. The tubulointerstitial injury and collagen deposition were evaluated using periodic acid-schiff stain and Masson staining. Renal tubular epithelial cell apoptosis was assessed using the terminal deoxynucleotidyl transferase dUTP nick end labeling assay, mitochondrial injury was observed using an electron microscope, and superoxide dismutase (SOD), glutathione (GSH) and malondialdehyde (MDA) levels were assessed using chromometry. Transforming growth factor-β1 (TGF-β1) expression was assessed using immunohistochemistry. The expressions of Bax, Bcl-2, peroxisome proliferator-activated receptor γ coactivator- 1α (PGC-1α), mitochondrial transcription factor A (Tfam), mitogen-activated protein kinases (MAPK) phosphorylation were evaluated by Western blot.
Results:
YSJZG decreased the 24-h urine protein, BUN, Scr, remnant kidney weight-to-body weight ratio, renal tubular injury, deposition of collagen, and the apoptosis of renal tubular epithelial cells in a dose-dependent manner. YSJZG dose-dependently restored the number and structure of mitochondria and the expression of Tfam and PCG-1α, up-regulated the expression of Bcl-2, and inhibited the expression of Bax. YSJZG also dose-dependently inhibited TGF-β1 expression, increased SOD and GSH activity, decreased the MDA level, and inhibited p38MAPK and pERK1/2 phosphorylation (all P<0.01).
Conclusion:
YSJZG improved the renal function in rats with CRF and inhibited the progression of tubulointerstitial fibrosis by dose-dependently alleviating mitochondrial injury, restoring the expression of Tfam and PCG-1α, and inhibiting renal tubular epithelial cell apoptosis through inhibiting activation of reactive oxygen species-MAPK signaling.
Insights
Yishen Jiangzhuo Granules (YSJZG) treatment improved renal function in chronic renal failure (CRF) rats. YSJZG alleviated mitochondrial injury and renal tubular cell apoptosis, inhibiting tubulointerstitial fibrosis progression.
Area of Science:
- Nephrology
- Pharmacology
- Molecular Biology
Background:
- Chronic renal failure (CRF) is characterized by progressive kidney damage, often involving mitochondrial dysfunction and tubular cell apoptosis.
- Understanding the molecular mechanisms underlying CRF progression is crucial for developing effective treatments.
Purpose of the Study:
- To investigate the therapeutic effects of Yishen Jiangzhuo Granules (YSJZG) on mitochondrial injury and renal tubular epithelial cell apoptosis in a rat model of CRF.
- To elucidate the underlying molecular mechanisms, including gene and protein expression, and signaling pathways involved.
Main Methods:
- A 5/6 nephrectomy rat model of CRF was established and treated with varying doses of YSJZG or a control drug for 10 weeks.
- Evaluations included serum markers (creatinine, BUN, urine protein), histological analysis (tubulointerstitial injury, collagen deposition), apoptosis assays, mitochondrial morphology assessment, and Western blot analysis for key proteins (Bax, Bcl-2, PGC-1α, Tfam, MAPK).
Main Results:
- YSJZG significantly reduced markers of renal damage (urine protein, BUN, Scr) and tubulointerstitial fibrosis in a dose-dependent manner.
- Treatment with YSJZG restored mitochondrial structure and function, upregulated protective proteins (Bcl-2, Tfam, PGC-1α), and downregulated pro-apoptotic proteins (Bax).
- YSJZG inhibited TGF-β1 expression, reduced oxidative stress markers (MDA), and decreased MAPK phosphorylation (p38MAPK, pERK1/2).
Conclusions:
- Yishen Jiangzhuo Granules demonstrate significant renoprotective effects in CRF rats.
- YSJZG ameliorates renal dysfunction and inhibits tubulointerstitial fibrosis by alleviating mitochondrial injury and apoptosis.
- The mechanism involves restoring mitochondrial biogenesis markers and inhibiting the reactive oxygen species-MAPK signaling pathway.
More Related Videos
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
Related Concept Videos
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Cellular Injury V: Apoptosis and Autophagy